Sierra Ketamine Clinics of Reno
to Have Grand Opening & Ribbon Cutting Ceremony

Thursday, October 19 from 4:00 – 7:00pm

SKC Grand Opening


Sierra Ketamine Clinics, the first and only facility of its kind in the region, celebrated its grand opening with a ribbon cutting ceremony on Thursday, October 19. The event was a tremendous success and we extend our thanks and appreciation to all who attended and participated in the celebration. Many of the Truckee Meadows finest practitioners visited SKC to understand how they can improve their patients' difficult-to-treat conditions.

Regionally located facility to provide relief to those who suffer from chronic pain and depression.

Sierra Ketamine Clinics, located at 15 McCabe Drive Suite 203 in Reno, will celebrate its grand opening with a ribbon cutting ceremony on Thursday, October 19 from 4:00 – 7:00pm.

The first and only facility of its kind in the region, Bret Frey, M.D. and Robert Watson, M.D. have opened the doors to Sierra Ketamine Clinics to assist those who suffer from chronic pain, depression, and additional mental ailments such as PTSD, anxiety, and bipolar disorders.

With four treatment rooms meant to soothe the mind and body, compassionate and caring staff assist while patients relax in plush recliners, experiencing an aromatherapy-enhanced and stress-free environment during their treatment sessions.

Ketamine, a drug that has been around the medical community since the early 1960’s as an anesthetic, often gets media attention due to its misuse as a party drug or because of its use in veterinary medicine.

“It wasn’t until the early 2000s that researchers noted the surprising and unexpected effects of Ketamine on depression,” Frey, said. “Patients receiving Ketamine showed a vast improvement in their moods or depression, often within minutes or hours of receiving the medication. This was in stark contrast to the long delay of four to six weeks of other anti-depressant medications required to work. For patients we’ve treated, we’ve found similar results.”

Thomas Insel, former director of the National Institute of Mental Health was quoted saying, “Recent data suggests that Ketamine given intravenously, might be the most important breakthrough in antidepressant treatment in decades.” Depression is reported to effect up to 17% of the population in the United States. More than one of every 10 Americans takes an antidepressant medication. A 2008 Harvard Medical School study led by Dr. Irving Kirsch revealed that for those with mild-to-moderate depression, anti-depressant medications are almost no different from a placebo.

According to Watson, “Unfortunately for many, typical antidepressant medications have poor results or none at all. Ketamine operates differently with almost immediate results and radical improvements for patients. Most studies find about three of every four patients will benefit from the Ketamine therapy and that’s why we wanted to bring this innovation to northern Nevada. Although repeated doses of Ketamine are usually required, it often results in longer periods of remission and benefits.”

Chronic inflammation and stress are known to cause anatomical and physiological changes in the brain that can lead to depression. Neurons responsible for brain function are lost and the connection between neurons are essentially pruned. The necessary ability of the brain to adapt and change is therefore compromised. Ketamine is shown to reverse these changes almost immediately resulting in a radical improvement for many patients on the same day as the Ketamine treatment.